Evidence map›Paper›PMID 42567898›Full record

ReviewBritish journal of cancer2026

A functional landscape for chromosome 17q in neuroblastoma: balancing replication stress and genomic stability.

Elien Hilgert, Lisa Depestel, Nadine Van Roy, Stephen Roberts, Kaat Durinck, Frank Speleman

Abstract readReview
PubMed Publisher
In one paragraph

Review in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elien HilgertDepartment of Biomolecular Medicine, Faculty of Medicine & Health Sciences, Ghent University; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.ORCID http://orcid.org/0000-0002-4715-6972
Lisa DepestelDepartment of Biomolecular Medicine, Faculty of Medicine & Health Sciences, Ghent University; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.ORCID http://orcid.org/0000-0001-5690-3258
Nadine Van RoyDepartment of Biomolecular Medicine, Faculty of Medicine & Health Sciences, Ghent University; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Stephen RobertsDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
Kaat Durinck *Department of Biomolecular Medicine, Faculty of Medicine & Health Sciences, Ghent University; Cancer Research Institute Ghent (CRIG), Ghent, Belgium. kaat.durinck@ugent.be.ORCID http://orcid.org/0000-0003-1762-5739
Frank Speleman *Department of Biomolecular Medicine, Faculty of Medicine & Health Sciences, Ghent University; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.ORCID http://orcid.org/0000-0002-6628-8559

Funding

Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 11C3921NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G087221N
6 · The paper itself

Abstract

Neuroblastoma is characterised by extensive genomic instability despite a marked paucity of recurrent somatic mutations. Instead, the disease is predominantly driven by chromosomal alterations, including segmental chromosomal imbalances, small structural variants, and oncogene amplification. A major unmet challenge is identifying key oncogenic drivers, beyond MYCN amplification, hidden within these recurrent DNA copy number alterations. Extra wild-type gene copies can alter expression levels and thus contribute to tumour development and affect survival. Increasing evidence suggests that these copy number-affected genes confer resistance to replication stress, a hallmark of high-risk neuroblastoma tumours. Among the most frequent and prognostically significant alterations is the gain of chromosome 17q. In this review, we discuss selected top-ranked candidate genes on 17q implicated in replication fork dynamics and DNA damage repair that we previously identified through an integrative functional genomics study. Improved understanding of the mechanisms by which 17q copy number-driven genes regulate replication stress responses and DNA damage repair may expose fundamental vulnerabilities in aggressive neuroblastoma and guide the development of novel targeted therapeutic strategies.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.